Scancell Holdings Share News (SCLP)
SCLP Share
SCLP Share
SCLP Share
SCLP Share
SCLP
SCLP Share
SCLP Level 2
SCLP Live
SCLP Broker
SCLP Directors
SCLP Financial
SCLP
SCLP Short
SCLP
Last checked at -
Thu, 31st Jan 2013 15:04
(Sharecast News) - Immunotherapy developer Scancell announced the appointment of Sath Nirmalananthan as its new chief financial officer on Tuesday, effective immediately.
Read more
Scancell Holdings PLC - Nottingham, England-based cancer immunotherapies developer - Hires Sath Nirmalananthan to be chief financial officer, starting immediately. Nirmalananthan previously was CFO for Europe, Middle East & Africa at Prenetics Ltd, a genomics-driven health sciences company. His appointment at Scancell follows Keith Green's retirement as director of finance.
Read more(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.
Read more(Alliance News) - Scancell Holdings PLC on Monday said it has expanded its Modi-1 trial for the use of checkpoint inhibitors on cancer patients.
Read moreScancell Holdings PLC - Nottingham, England-based cancer immunotherapies developer - Will focus on lead cancer vaccine assets SCIB1 and Modi-1 following encouraging data from clinical trials. Adds phase two single arm scope trial investigating the safety and tolerability of using SCIB1 in combination with checkpoint inhibitors in patients with advanced melanoma is progressing well and notes a potential pathway for a registration trial. Adds it is fully funded to the second half of 2024 due to its increasing focus on the two clinical assets.
Read more(Sharecast News) - Immunotherapy developer Scancell said on Friday that it is set to present an informative poster at the American Society of Clinical Oncology Meeting (ASCO) 2023 annual meeting in Chicago from 2 to 6 June.
Read more(Alliance News) - The following is a round-up of updates on exposure to Silicon Valley Bank by London-listed companies, issued on Monday and not separately reported by Alliance News:
Read more(Sharecast News) - Immunotherapy developer Scancell announced the completion of the monotherapy dose-finding arm of the phase 1 and 2 'ModiFY' clinical trial on Tuesday.
Read more(Alliance News) - Scancell Holdings PLC on Tuesday said that it has completed the monotherapy dose finding arm of its multicentre Phase 1/2 ModiFY clinical trial, designed to treat cancer patients.
Read more(Alliance News) - Scancell Holdings PLC on Monday reported a positive response in its 'Covidity' trial, which aims to deliver needle-free injectable Covid vaccines.
Read more(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:
Read more(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:
Read more| Thursday 19 January | |
| AJ Bell PLC | Trading Statement |
| Bakkavor Group PLC | Trading Statement |
| BHP Group Ltd | Trading Statement |
| boohoo Group PLC | Trading Statement |
| Centamin PLC | Trading Statement |
| Deliveroo PLC | Trading Statement |
| Dunelm Group PLC | Trading Statement |
| Energean PLC | Trading Statement |
| Frontier Developments PLC | Half Year Results |
| Harbour Energy PLC | Trading Statement |
| Headlam Group PLC | Trading Statement |
| Ilika PLC | Half Year Results |
| Kier Group PLC | Trading Statement |
| Luceco PLC | Trading Statement |
| Network International Holdings PLC | Trading Statement |
| Premier Foods PLC | Trading Statement |
| Sage Group PLC | Trading Statement |
| Zotefoams PLC | Trading Statement |
| Friday 20 January | |
| 4imprint Group PLC | Trading Statement |
| Close Brothers Group PLC | Trading Statement |
| Goldplat PLC | Full Year Results |
| Ninety One PLC | Trading Statement |
| Workspace Group PLC | Trading Statement |
| PensionBee Group PLC | Trading Statement |
| TheWorks.co.uk PLC | Half Year Results |
| Monday 23 January | |
| Oxford Cannabinoid Technologies Holdings PLC | Half Year Results |
| Tuesday 24 January | |
| Accrol Group Holdings PLC | Half Year Results |
| Associated British Foods PLC | Trading Statement |
| Henry Boot PLC | Trading Statement |
| Oxford BioDynamics PLC | Full Year Results |
| Saga PLC | Trading Statement |
| Staffline Group PLC | Trading Statement |
| Sureserve Group PLC | Full Year Results |
| Velocity Composites PLC | Full Year Results |
| Wednesday 25 January | |
| CMC Markets PLC | Trading Statement |
| Conduit Holdings Ltd | Trading Statement |
| easyJet PLC | Trading Statement |
| Forterra PLC | Trading Statement |
| Hargreaves Services PLC | Half Year Results |
| hVIVO PLC | Trading Statement |
| JD Wetherspoon PLC | Trading Statement |
| Keywords Studios PLC | Trading Statement |
| Quilter PLC | Trading Statement |
| Scancell Holdings PLC | Half Year Results |
| Tullow Oil PLC | Trading Statement |
| Van Elle Holdings PLC | Half Year Results |
| Watkin Jones PLC | Full Year Results |
| Copyright 2023 Alliance News Ltd. All Rights Reserved. |
(Alliance News) - Scancell Holdings PLC on Monday said it has in-licensed SNAPvax technology from Vaccitech PLC to help develop its cancer treatments.
Read more(Sharecast News) - Scancell has in-licensed 'SNAPvax' technology from clinical-stage biopharmaceutical company Vaccitech, it announced on Monday.
Read more
Last checked at